A national audit of pancreatic enzyme prescribing in pancreatic cancer from 2015 to 2023 in England using OpenSAFELY-TPP

OBJECTIVES: Cancer treatments were variably disrupted during the COVID-19 pandemic. UK guidelines recommend pancreatic enzyme replacement therapy (PERT) to all people with unresectable pancreatic cancer. The aim was to investigate the impact of COVID-19 on PERT prescribing to people with unresectabl...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Semin Oncol Nurs
Auteurs principaux: Lemanska, Agnieszka, Andrews, Colm, Fisher, Louis, Butler-Cole, Ben, Mehrkar, Amir, Roberts, Keith J, Goldacre, Ben, Walker, Alex J, MacKenna, Brian
Format: Artigo
Langue:Inglês
Publié: 2023
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616357/
https://ncbi.nlm.nih.gov/pubmed/37142468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.soncn.2023.151439
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires